Zelefsky MJ - Search Results

1

Leibel SA, Fuks Z, Zelefsky MJ, Wolden SL, Rosenzweig KE, Alektiar KM, Hunt MA, Yorke ED, Hong LX, Amols HI, Burman CM, Jackson A, Mageras GS, LoSasso T, Happersett L, Spirou SV, Chui CS, Ling CC. Leibel SA, et al. Among authors: zelefsky mj. Cancer J. 2002 Mar-Apr;8(2):164-76. doi: 10.1097/00130404-200203000-00010. Cancer J. 2002. PMID: 12004802

2

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy.

Zelefsky MJ, Scher HI, Krol G, Portenoy RK, Leibel SA, Fuks ZY. Zelefsky MJ, et al. Cancer. 1992 Nov 1;70(9):2319-25. doi: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>3.0.co;2-8. Cancer. 1992. PMID: 1394060

3

Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens.

Zelefsky MJ, Scher HI, Forman JD, Linares LA, Curley T, Fuks Z. Zelefsky MJ, et al. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1281-5. doi: 10.1016/0360-3016(89)90537-3. Int J Radiat Oncol Biol Phys. 1989. PMID: 2480941 Clinical Trial.

4

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

Leibel SA, Heimann R, Kutcher GJ, Zelefsky MJ, Burman CM, Melian E, Orazem JP, Mohan R, LoSasso TJ, Lo YC, et al. Leibel SA, et al. Among authors: zelefsky mj. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):55-65. doi: 10.1016/0360-3016(94)90141-4. Int J Radiat Oncol Biol Phys. 1994. PMID: 7505776 Clinical Trial.

5

Short-term freedom from disease progression after I-125 prostate implantation.

Wallner K, Roy J, Zelefsky M, Fuks Z, Harrison L. Wallner K, et al. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):405-9. doi: 10.1016/0360-3016(94)90021-3. Int J Radiat Oncol Biol Phys. 1994. PMID: 7523345

6

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer.

Zelefsky MJ, Leibel SA, Wallner KE, Whitmore WF Jr, Fuks Z. Zelefsky MJ, et al. J Clin Oncol. 1995 Feb;13(2):459-63. doi: 10.1200/JCO.1995.13.2.459. J Clin Oncol. 1995. PMID: 7531221

7

Refining the predictive power of the prostate-specific antigen.

Zelefsky MJ, Fuks Z, Leibel SA. Zelefsky MJ, et al. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):171-2. doi: 10.1016/0360-3016(93)90435-x. Int J Radiat Oncol Biol Phys. 1993. PMID: 7690015 No abstract available.

8

Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study.

Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Kelson S, Fuks Z. Leibel SA, et al. Among authors: zelefsky mj. J Urol. 1994 Nov;152(5 Pt 2):1792-8. doi: 10.1016/s0022-5347(17)32387-x. J Urol. 1994. PMID: 7933238 Clinical Trial.

9

The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate.

Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Mohan R, Mageras GS, Ling CC, Fuks Z. Leibel SA, et al. Among authors: zelefsky mj. Semin Oncol. 1994 Oct;21(5):580-97. Semin Oncol. 1994. PMID: 7939749 Review. No abstract available.

10

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy.

Zelefsky MJ, Leibel SA, Burman CM, Kutcher GJ, Harrison A, Happersett L, Fuks Z. Zelefsky MJ, et al. Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):755-61. doi: 10.1016/0360-3016(94)90563-0. Int J Radiat Oncol Biol Phys. 1994. PMID: 8040021 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page